Ticker > Company >

Divi''s Lab share price

Divi''s Laboratories Ltd.

NSE: DIVISLAB BSE: 532488 SECTOR: Pharmaceuticals & Drugs  4.28 L   2.73 K   689

6588.40
-30.25 (-0.46%)
BSE: 28 Jul 04:01 PM

Price Summary

Today's High

₹ 6709

Today's Low

₹ 6557.35

52 Week High

₹ 7077.7

52 Week Low

₹ 4617.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

174901.32 Cr.

Enterprise Value

171207.32 Cr.

No. of Shares

26.55 Cr.

P/E

79.18

P/B

11.74

Face Value

₹ 2

Div. Yield

0.46 %

Book Value (TTM)

₹  561.09

CASH

3696 Cr.

DEBT

2 Cr.

Promoter Holding

51.89 %

EPS (TTM)

₹  83.21

Sales Growth

20%

ROE

15.57 %

ROCE

20.65%

Profit Growth

40.17 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Divi''s Laboratories Ltd.

Carotenoids Lutein Beta-Carotene Naproxen Dextromethorphan Gabapentin

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year20%
3 Year1.18%
5 Year11.61%

Profit Growth

1 Year40.16%
3 Year-9.18%
5 Year9.98%

ROE%

1 Year15.57%
3 Year14.14%
5 Year18.82%

ROCE %

1 Year20.65%
3 Year18.76%
5 Year24.6%

Debt/Equity

0.0001

Price to Cash Flow

106

Interest Cover Ratio

1465.5

CFO/PAT (5 Yr. Avg.)

0.878428125827676

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 51.89 0.00
Mar 2025 51.89 0.00
Dec 2024 51.89 0.00
Sep 2024 51.89 0.00
Jun 2024 51.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 1465.5.
  • The Company has been maintaining an effective average operating margins of 35.1638248200699% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 4.8693.
  • The company has a high promoter holding of 51.89%.

 Limitations

  • The company has shown a poor profit growth of -9.17691894564887% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.18039331826569% for the Past 3 years.
  • The company is trading at a high PE of 79.18.
  • The company is trading at a high EV/EBITDA of 51.3827.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 2259 2063 2302 2297 2536
Total Expenditure 1542 1442 1573 1550 1655
Operating Profit 717 621 729 747 881
Other Income 79 79 105 82 87
Interest 2 0 1 0 0
Depreciation 94 97 98 99 107
Exceptional Items 0 0 0 0 0
Profit Before Tax 700 603 735 730 861
Tax 169 173 217 136 194
Profit After Tax 531 430 518 594 667
Adjusted EPS (Rs) 20.04 16.23 19.55 22.42 25.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 6798.61 8879.82 7625 7665 9198
Total Expenditure 3977.73 5005.05 5276 5490 6218
Operating Profit 2820.88 3874.77 2349 2175 2980
Other Income 63.45 114.03 349 337 352
Interest 1.81 1.73 2 4 2
Depreciation 254.65 310.55 342 376 401
Exceptional Items 0 0 0 0 0
Profit Before Tax 2627.87 3676.52 2354 2132 2929
Tax 673.15 727.98 546 556 720
Net Profit 1954.72 2948.54 1808 1576 2209
Adjusted EPS (Rs.) 73.64 111.08 68.23 59.47 83.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 53.09 53.09 53 53 53
Total Reserves 9218.48 11638.26 12652 13431 14842
Borrowings 0 0 0 0 0
Other N/C liabilities 363.48 448.11 568 619 509
Current liabilities 1704.78 2427.29 1511 1730 2212
Total Liabilities 11339.83 14566.75 14784 15833 17616
Assets
Net Block 3699.01 4320.97 4719 4737 5440
Capital WIP 710.62 469.93 212 778 1022
Intangible WIP 0 0 0 0 0
Investments 7.37 79.37 84 89 72
Loans & Advances 172.42 133.58 97 176 301
Other N/C Assets 9.21 8.05 4 10 10
Current Assets 6741.2 9554.85 9668 10043 10771
Total Assets 11339.83 14566.75 14784 15833 17616
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2627.87 3676.52 2354 2132 2929
Adjustment 186.66 235.32 118 72 113
Changes in Assets & Liabilities -234.52 -1371.89 447 -565 -574
Tax Paid -632.96 -629.79 -472 -373 -818
Operating Cash Flow 1947.05 1910.16 2447 1266 1650
Investing Cash Flow 75.34 -2195.4 -2707 -268 -803
Financing Cash Flow -33.97 -531.5 -796 -798 -797
Net Cash Flow 1988.42 -816.74 -1056 200 50

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 51.90 51.89 51.89 51.89 51.89
madhusudana rao divi 0.08 0.07 0.07 0.07 0.07
murali krishna prasad div... 2.85 2.85 2.85 2.85 2.85
nilima prasad divi 20.34 20.34 20.34 20.34 20.34
satchandra kiran divi 20.34 20.34 20.34 20.34 20.34
swarna latha divi 5.27 5.27 5.27 5.27 5.27
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 48.10 48.11 48.11 48.11 48.11
axis mutual fund trustee ... 1.60 1.50 1.39 1.39 1.30
government of singapore - 1.77 2.38 2.26 2.64
government pension fund g... 1.63 1.53 1.34 1.32 1.35
hdfc mutual fund - - - - 1.01
investor education and pr... 0.01 - 0.01 - 0.01
life insurance corporatio... 6.73 6.95 6.03 5.63 3.94
nippon life india trustee... 1.07 1.18 1.18 1.20 1.16
sbi mutual fund 7.41 5.65 5.36 4.97 4.79
investor education and pr... - 0.01 - 0.01 -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research Geojit
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research Motilal Oswal
Research ICICI Securities Limited
Research BOB Capital Markets Ltd.

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q4FY21
Concall Q3FY25
Concall Q3FY24
Concall Q3FY21
Concall Q2FY22
Concall Q2FY21
Concall Q1FY25
Concall Q1FY23
Concall Q1FY22
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Divi''s Lab Stock Price Analysis and Quick Research Report. Is Divi''s Lab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Divi''s Lab and its performance over the period of time. Divi''s Lab stock price today is Rs 6584.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Divi''s Lab cash from the operating activity was Rs 1650 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Divi''s Lab has a Debt to Equity ratio of 0.0001 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Divi''s Lab , the EPS growth was 40.165 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Divi''s Lab has OPM of 32.3983474668406 % which is a good sign for profitability.
     
  • ROE: Divi''s Lab have a average ROE of 15.5678 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Divi''s Lab is Rs 6584. One can use valuation calculators of ticker to know if Divi''s Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Divi''s Lab
X